Navigation Links
UT Southwestern researchers uncover Fragile X syndrome gene's role in shaping brain
Date:5/7/2010

DALLAS May 11, 2010 Researchers at UT Southwestern Medical Center have discovered how the genetic mutation that causes Fragile X syndrome, the most common form of inherited mental retardation, interferes with the "pruning" of nerve connections in the brain. Their findings appear in the April 29 issue of Neuron.

Soon after birth, the still-developing brain of a mammal produces too many nerve connections that create "noise" in the nervous system. The brain finds it hard to process these signals, like a person trying to have a conversation at a loud party. But as the brain matures and learning takes place, some nerve connections naturally become stronger while others weaken and die, leading to an adult with a properly wired brain.

Fragile X is caused by a mutation in a single gene, Fmr1, on the X chromosome. The gene codes for a protein called FMRP, which plays a role in learning and memory but whose full function is unknown. The protein's role in pruning nerve connections had been unclear.

"I think we've uncovered a core function for the gene involved in this disease, and if we can find other biochemical methods involved in nerve pruning, we might be able to help correct this," said Dr. Kimberly Huber, associate professor of neuroscience at UT Southwestern and senior author of the study.

In the current study, Dr. Huber and her colleagues examined nerve cells isolated from mice that had been engineered to lack the Fmr1 gene and, therefore, did not produce FMRP protein. They then tested whether the lack of FMRP affected the functions of another protein called MEF2, which is known to be involved in pruning nerve connections.

The researchers found that nerve cells lacking FMRP were unable to respond to MEF2. Adding FMRP to the cells restored MEF2's normal function.

"We were massively activating the MEF2 gene in the cell, and it did absolutely nothing without FMRP," Dr. Huber said. Such an all-or-nothing requirement in a biochemical relationship is rare, she said.

The findings also raise questions about how the two proteins interact physically. MEF2 works in the nucleus of a cell, where it controls whether other genes are turned on or off. FMRP shuttles in and out of the cell's nucleus and into its main body.

"This opens up new ideas about how processes in the cell's nucleus, near its DNA, can affect the nerve connections, which are very far away at the other end of the cell," Dr. Huber said. "We think MEF2 is making messenger RNA [ribonucleic acid], which translates the genetic code of the DNA, and FMRP is binding to the RNA and either transporting it to the nerve connections and/or controlling how the RNA makes protein."

Further research will focus on the relationship between the proteins. For instance, one might directly control the other, or they might work together on a common target, Dr. Huber said.

"This work might not have clinical implications for quite a while," she said. "The goal for us as scientists is to understand how these genes relate to mechanisms that control the development of nerve connections."

Like other genetic diseases carried on the X chromosome, Fragile X syndrome strikes boys more often and more severely than girls. Girls have two X chromosomes, so a normal gene on one chromosome can mitigate the effects of the disease if the gene on the other X chromosome is abnormal. Boys, however, have only one X chromosome, so if they inherit an abnormal gene on the X chromosome, they have no protection.


'/>"/>

Contact: Aline McKenzie
aline.mckenzie@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
Source:Eurekalert

Related medicine news :

1. Urine protein test might help diagnose kidney damage from lupus, UT Southwestern researchers find
2. Parent mentors can improve the asthmatic care of minority children, UT Southwestern researchers find
3. U of T researchers crack splicing code, solve a mystery underlying biological complexity
4. PMH cancer researchers link ovarian hormone to breast stem cells growth
5. Researchers find future temperatures could exceed livable limits
6. Researchers make advances in understanding causes, treatments and outcomes of liver disease
7. Researchers attack stem cells that cause colon cancer
8. Nutrition researchers to develop new growth charts for children with Down syndrome
9. MU researchers show potential for new cancer detection and therapy method
10. Researchers successfully lower radiation dose associated with pediatric chest CT scans
11. Researchers identify a new breast and ovarian cancer susceptibility gene
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... SANTA CLARA, CA (PRWEB) , ... July 20, ... ... some form of travel protection services since 2014, top travel insurance solution company ... agents the tools to sell all major international travel insurance products online, under ...
(Date:7/20/2017)... , ... July 19, 2017 , ... At Creekwood Dental ... of temporomandibular joint (TMJ) treatment and dental implants in Waco, TX, using ... scanner and the T-Scan™ by Tekscan®, they can capture details in the oral cavity ...
(Date:7/20/2017)... ... 2017 , ... A July 7th article on ... veins in some patients, according to medical experts. Washington State medical clinic Northwest ... sitting or standing, or regularly nicking yourself while shaving your legs, and taking ...
(Date:7/18/2017)... ... July 18, 2017 , ... ClinicalTrials.gov and the New ... Need to Consider?, **An FDAnews Webinar**, Aug. 2, 2017 — 1:30 p.m. – ... Rule for Clinical Trials Registration and Results Information,” is a head-scratcher. After reading ...
(Date:7/18/2017)... ... ... Heritage Woods of Benton, a Gardant affordable assisted living community is hosting ... The community, which is located at 1305 Bailey Lane in Benton, Illinois, serves older ... their independence. , The lunch menu will include Hawaiian chicken, meatballs and coleslaw. Tropical ...
Breaking Medicine News(10 mins):
(Date:7/5/2017)... JERUSALEM , July 5, 2017 ... www.oramed.com ), a clinical-stage pharmaceutical company ... today that it has received approval from the Israel Securities ... Stock Exchange (TASE). Oramed common stock will commence trading on ... Based on the current market capitalization of the Company, it ...
(Date:7/1/2017)... 30, 2017 Zimmer Biomet Holdings, Inc. (NYSE and ... conference call will be broadcast live over the Internet on ... news release detailing the quarterly results will be made available ... call. The live audio webcast can be accessed ... It will be archived for replay following the conference call. ...
(Date:6/30/2017)... -- Axium Pharmaceuticals Inc. is a pharmaceutical company aimed at utilizing drug ... forms of existing biologically active molecule. ... Subveta oral spray ... formula, which is designed to prevent precipitation of the active ... provide fast onset of action and is designed to optimize ...
Breaking Medicine Technology: